Protalix BioTherapeutics (PLX) Current Taxes (2023 - 2026)

Protalix BioTherapeutics has reported Current Taxes for 4 years, with the latest figure at $4.2 million in Q2 2026.

• On a quarterly basis, Current Taxes rose 12.64% year-over-year to $4.2 million in Q2 2026; TTM through Jun 2026 was $4.2 million, a 12.64% increase from a year earlier, with the FY2025 full-year figure at $2.9 million, down 15.13% from the prior year.
• Current Taxes was $4.2 million for Q2 2026 at Protalix BioTherapeutics, up from $3.2 million in the prior quarter.
• The five-year high for Current Taxes was $4.2 million in Q2 2026, with the low at $2.4 million in Q3 2025.
• Average Current Taxes over 4 years is $3.3 million, with a median of $3.3 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Current Taxes gained 20.86% in 2024, then fell 15.13% in 2025.
• Over 4 years, Current Taxes stood at $2.9 million in 2023, then increased by 20.86% to $3.5 million in 2024, then slipped by 15.13% to $2.9 million in 2025, then jumped by 42.88% to $4.2 million in 2026.
• The last three Current Taxes figures came in at $4.2 million (Q2 2026), $3.2 million (Q1 2026), and $2.9 million (Q4 2025), per Business Quant data.